Arcutis Biotherapeutics, Inc. - Common stock (ARQT)

Rep. Josh Gottheimer's filing reports that a joint account purchased · $1,001 – $15,000 · Owner: Joint

Disclosures are reported transactions, not verified real-time portfolio holdings.